AXIM BIOTECHNOLOGIES, INC. (AXIM) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2023 | $0 | -100.0% |
| 2022 | $8.7K | -78.5% |
| 2021 | $40.5K | -58.4% |
| 2020 | $97.3K | — |
| 2016 | $0 | +100.0% |
| 2015 | -$16.8K | — |
| 2014 | $0 | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2023 | $0 | -100.0% |
| 2022 | $8.7K | -78.5% |
| 2021 | $40.5K | -58.4% |
| 2020 | $97.3K | — |
| 2016 | $0 | +100.0% |
| 2015 | -$16.8K | — |
| 2014 | $0 | — |